We propose that measuring the availability of potential tumor antigens and the infiltration of CD4+ and CD8+ T cells with cytotoxic phenotypes may aid in resolving the contradictory findings of these studies and provide a more complete picture of the tumor immune microenvironment. The gene discussed is CD8A; the disease is neoplasm.